Century Therapeutics, Inc. (IPSC) vs Lexeo Therapeutics, Inc. Common Stock (LXEO)
A side-by-side comparison of Century Therapeutics, Inc. and Lexeo Therapeutics, Inc. Common Stock across valuation, profitability, dividends, and growth — built entirely from reported fundamentals, as of October 6, 2026. Differences are shown without an overall score or investment verdict.
IPSC
Century Therapeutics, Inc.
$1.41HealthcareDelayed quote: Oct 6, 2026, 10:25 AM EDT
LXEO
Lexeo Therapeutics, Inc. Common Stock
$3.19HealthcareDelayed quote: Oct 6, 2026, 10:25 AM EDT
Total return — IPSC vs LXEO
growth of $100 · dividends reinvested · last 3yIPSC -3.3% (-1.1%/yr)LXEO -66.1% (-30.3%/yr)IPSC compounded faster over this window
IPSC LXEO
IPSC vs LXEO: by the numbers
- •IPSC is the larger company ($255M vs $250M market cap).
- •Both run net losses; LXEO's is the smaller (0.00% vs -8.78% net margin).
Metrics side by side
Valuation
| Metric | IPSC | LXEO |
|---|---|---|
| P/B ratio | 1.10 | 1.06 |
Profitability
| Metric | IPSC | LXEO |
|---|---|---|
| Gross margin | 88.00% | 0.00% |
| Operating margin | -13.78% | 0.00% |
| Net margin | -8.78% | 0.00% |
| ROE | -47.25% | -37.12% |
| ROIC | -43.69% | -39.76% |
Growth (annualized)
| Metric | IPSC | LXEO |
|---|---|---|
| Total return CAGR (5Y) | -42.05% | N/A |
Go deeper
Dig into the metrics
Century Therapeutics ROELexeo Therapeutics, Inc. Common Stock ROECentury Therapeutics operating marginLexeo Therapeutics, Inc. Common Stock operating marginCentury Therapeutics revenue growthLexeo Therapeutics, Inc. Common Stock revenue growthCentury Therapeutics free cash flowLexeo Therapeutics, Inc. Common Stock free cash flow
Figures are sourced from reported fundamentals and the latest end-of-day price. This comparison is informational only and is not investment advice. Past performance does not predict future results. See our methodology. Compiled by TGMCharts Research · data verified October 6, 2026.